| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2658d45a8e9c71b9598e2bf83242bab3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2812 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2013-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df11671bd78b4406b23c70beba2d9fcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36daea1d9345ee280b760f30d77c3522 |
| publicationDate |
2014-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014248295-A1 |
| titleOfInvention |
Glycan-modified anti-cd4 antibodies for hiv prevention and therapy |
| abstract |
Disclosed herein are glycan-modified anti-CD4 monoclonal antibodies with N-linked glycans attached to the variable region. Expression vectors and cell lines useful for the production of such antibodies, and use of such antibodies for HIV prevention and therapy are also disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016149695-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9790276-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10450368-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10654943-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016196740-A1 |
| priorityDate |
2012-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |